IceCure Medical (ICCM) Invested Capital (2020 - 2025)
IceCure Medical (ICCM) has disclosed Invested Capital for 6 consecutive years, with $9.1 million as the latest value for Q4 2025.
- Quarterly Invested Capital rose 31.15% to $9.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Dec 2025, up 31.15% year-over-year, with the annual reading at $9.1 million for FY2025, 31.15% up from the prior year.
- Invested Capital for Q4 2025 was $9.1 million at IceCure Medical, up from $6.9 million in the prior quarter.
- The five-year high for Invested Capital was $27.0 million in Q4 2021, with the low at $6.9 million in Q4 2024.
- Average Invested Capital over 5 years is $16.1 million, with a median of $12.2 million recorded in 2023.
- The sharpest move saw Invested Capital surged 377.3% in 2021, then crashed 52.16% in 2023.
- Over 5 years, Invested Capital stood at $27.0 million in 2021, then dropped by 5.7% to $25.4 million in 2022, then crashed by 52.16% to $12.2 million in 2023, then crashed by 43.26% to $6.9 million in 2024, then soared by 31.15% to $9.1 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods came in at $9.1 million, $6.9 million, and $12.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.